European companies whose shares trade on US exchanges as American depositary receipts (ADRs) mostly edged lower Friday morning, pulling the S&P Europe Select ADR Index down 0.6%. The dip came even as some notable names, including bank NatWest and chip designer Arm, managed to post gains.
An ADR is a US-listed certificate that represents shares in a foreign company, allowing investors to buy and sell overseas stocks in dollars during regular US trading hours. The S&P Europe Select ADR Index tracks a basket of these instruments, offering a quick snapshot of how some of Europe's biggest companies are faring on Wall Street.
Healthcare heavyweights drag the index
The index doesn't move on a simple majority-rules basis. Like most market benchmarks, it is weighted by company size, meaning a few large stocks can steer the entire index. That was the case on Friday, as healthcare laggards put significant pressure on the overall number.
Danish drugmaker Novo Nordisk fell 4.5%, while Spanish pharmaceutical and diagnostics firm Grifols dropped 8.6%. Together, they led the declines and were the primary drivers of the index's slide. The moves highlight how a handful of big names can dominate a broad market gauge.
For context, Novo Nordisk has been one of Europe's most valuable companies in recent years, thanks to its blockbuster weight-loss and diabetes treatments. Grifols, meanwhile, has faced its own challenges, including a turbulent period tied to its debt load and accounting questions that surfaced earlier this year.
Friday's decline in these healthcare names comes during a busy stretch for European earnings, with major companies like HSBC, BP, and Novo Nordisk reporting results. Investors have been watching closely to see how these firms are navigating inflation, interest rates, and shifting consumer demand.
Banks and tech buck the trend
Not every European ADR fell on Friday. NatWest, the UK-based bank, rose, continuing a recent pattern where bank stocks have led gains in European ADR trading. Banks often benefit from higher interest rates, which can widen the gap between what they pay on deposits and what they earn on loans.
Arm, the UK-based chip designer, also gained. Arm's business is tied to the global semiconductor industry, which has seen renewed investor enthusiasm as demand for artificial intelligence and data center chips surges. The company's ADR has been a favorite among tech investors, and its rise on Friday helped offset some of the healthcare-led losses.
The mixed performance underscores the diversity within the European ADR universe, which spans everything from banks and energy producers to healthcare and technology firms.
What it means for investors
For everyday investors, the S&P Europe Select ADR Index is a convenient way to gauge how European markets are moving without having to track dozens of individual stocks. A 0.6% dip is relatively modest and doesn't signal a major shift in sentiment, but it does show that not all European companies are moving in the same direction.
Investors holding ADRs in healthcare names like Novo Nordisk or Grifols may feel the sting of Friday's declines, but it's worth remembering that single-day moves are often driven by company-specific news or broader sector trends rather than a fundamental change in the business.
For those with diversified portfolios, the index's performance is a reminder that international exposure can add volatility. European stocks have had a mixed year, with some sectors like energy and banks performing well while others, such as healthcare and consumer goods, have faced headwinds. Energy has been a key driver of Europe's profit growth, while other industries have lagged.
Looking ahead, investors will likely keep an eye on central bank policy, particularly the European Central Bank and the Bank of England, as they navigate inflation and growth. The Bank of England recently held rates steady, a sign that policymakers are waiting to see how the economy evolves before making further moves.
For now, Friday's slip in European ADRs is a reminder that markets rarely move in lockstep. Even when the overall index falls, there are always winners and losers beneath the surface.
